CLSH Stock Overview
CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
CLS Holdings USA, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.055 |
52 Week High | US$0.12 |
52 Week Low | US$0.027 |
Beta | 1.44 |
1 Month Change | 10.00% |
3 Month Change | 32.85% |
1 Year Change | 10.00% |
3 Year Change | -93.60% |
5 Year Change | -95.25% |
Change since IPO | -98.17% |
Recent News & Updates
Recent updates
Shareholder Returns
CLSH | US Consumer Retailing | US Market | |
---|---|---|---|
7D | 9.1% | -2.0% | -3.7% |
1Y | 10.0% | 15.1% | 20.5% |
Return vs Industry: CLSH underperformed the US Consumer Retailing industry which returned 15.1% over the past year.
Return vs Market: CLSH underperformed the US Market which returned 20.5% over the past year.
Price Volatility
CLSH volatility | |
---|---|
CLSH Average Weekly Movement | 21.1% |
Consumer Retailing Industry Average Movement | 4.6% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.4% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CLSH's share price has been volatile over the past 3 months.
Volatility Over Time: CLSH's weekly volatility has decreased from 27% to 21% over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | n/a | Andrew Glashow | www.clsholdingsinc.com |
CLS Holdings USA, Inc., a diversified cannabis company, focuses on the extraction and conversion of cannabinoids in the United States. It extracts cannabinoids from the cannabis plants and converts into concentrates, that includes oils, waxes, edibles, and shatters; and provides toll processing services. The company also sells organic medical cannabis to licensed retailers; recreational marijuana cannabis products to licensed distributors and retailers; extraction products, such as oils and waxes derived from in-house cannabis production; and offers processing and extraction services for licensed medical cannabis cultivators, as well as cannabis strains in the form of vegetative cuttings to licensed medical cannabis cultivators.
CLS Holdings USA, Inc. Fundamentals Summary
CLSH fundamental statistics | |
---|---|
Market cap | US$7.57m |
Earnings (TTM) | -US$9.67m |
Revenue (TTM) | US$20.82m |
0.4x
P/S Ratio-0.8x
P/E RatioIs CLSH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CLSH income statement (TTM) | |
---|---|
Revenue | US$20.82m |
Cost of Revenue | US$12.06m |
Gross Profit | US$8.76m |
Other Expenses | US$18.43m |
Earnings | -US$9.67m |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.07 |
Gross Margin | 42.06% |
Net Profit Margin | -46.46% |
Debt/Equity Ratio | -61.1% |
How did CLSH perform over the long term?
See historical performance and comparison